Advertisement

Ampio Pharmaceuticals, Inc. AMPE

Set alert

Price alert · AMPE

All alert types
0.18 USD 0.00 0.00%

At close · Oct 29

0.0052 Day range 0.0052
0.0052 52-week range 0.64
YTD
+3,421.15%
1 year
+3,421.15%
Open
0.0052
Prev close
0.1831
Mkt cap
207.88K
Vol
334
Avg vol
0
EPS
-722.91
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0052
High
0.0052
Forward P/E
-3.39
Beta
1.95
Short ratio
0.31
Inst. own
4.19%
Dividend
0.00
Ex-div date
Earnings
Dec 24, 2024
50-d avg
1.49
200-d avg
2.82
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Dec 24, 2024Earnings: —; estimate 0; surprise —%
Signals (98)
NameDateAgo
SMA: BullishJul 21, 20263 months ago
SMA: BearishJul 16, 20263 months ago
MACD: Sell SignalJun 2, 20265 months ago
SMA: BullishMay 13, 20265 months ago
SMA: BearishMay 8, 20265 months ago
SMA: BullishMay 7, 20265 months ago
SMA: BullishMay 7, 20265 months ago
MACD: Buy SignalMay 7, 20265 months ago
RSI: OverboughtMay 7, 20265 months ago
SMA: BearishApr 24, 20266 months ago
SMA: BearishApr 24, 20266 months ago
MACD: Sell SignalApr 24, 20266 months ago
RSI: OversoldApr 24, 20266 months ago
SMA: BullishApr 14, 20266 months ago
MACD: Buy SignalApr 14, 20266 months ago
SMA: BullishMar 26, 20267 months ago
SMA: BearishMar 24, 20267 months ago
SMA: BearishMar 24, 20267 months ago
RSI: OversoldMar 24, 20267 months ago
MACD: Sell SignalMar 16, 20267 months ago
RSI: OverboughtFeb 24, 20268 months ago
MACD: Buy SignalFeb 20, 20268 months ago
SMA: BullishFeb 19, 20268 months ago
SMA: BullishFeb 19, 20268 months ago
SMA: BearishFeb 2, 20269 months ago
SMA: BearishFeb 2, 20269 months ago
RSI: OversoldFeb 2, 20269 months ago
MACD: Sell SignalJan 29, 20269 months ago
SMA: BullishJan 8, 20269 months ago
SMA: BullishJan 8, 20269 months ago
RSI: OverboughtJan 8, 20269 months ago
MACD: Buy SignalJan 6, 20269 months ago
SMA: BearishDec 23, 202510 months ago
SMA: BearishDec 23, 202510 months ago
SMA: BullishDec 22, 202510 months ago
SMA: BullishDec 22, 202510 months ago
MACD: Sell SignalDec 15, 202510 months ago
SMA: BearishDec 10, 202510 months ago
SMA: BearishDec 10, 202510 months ago
SMA: BullishDec 9, 202510 months ago
SMA: BullishDec 9, 202510 months ago
MACD: Buy SignalDec 9, 202510 months ago
RSI: OverboughtDec 9, 202510 months ago
MACD: Sell SignalNov 20, 202511 months ago
SMA: BearishNov 18, 202511 months ago
SMA: BearishNov 18, 202511 months ago
SMA: BullishNov 17, 202511 months ago
SMA: BullishNov 17, 202511 months ago
MACD: Buy SignalNov 17, 202511 months ago
MACD: Sell SignalNov 3, 202512 months ago
SMA: BearishOct 29, 20251 year ago
SMA: BearishOct 29, 20251 year ago
SMA: BullishOct 27, 20251 year ago
SMA: BullishOct 27, 20251 year ago
MACD: Buy SignalOct 27, 20251 year ago
RSI: OverboughtOct 27, 20251 year ago
MACD: Sell SignalOct 6, 20251 year ago
SMA: BearishOct 3, 20251 year ago
SMA: BearishOct 3, 20251 year ago
SMA: BullishOct 2, 20251 year ago
SMA: BullishOct 2, 20251 year ago
MACD: Buy SignalOct 2, 20251 year ago
RSI: OverboughtOct 2, 20251 year ago
MACD: Sell SignalSep 29, 20251 year ago
SMA: BearishSep 25, 20251 year ago
SMA: BearishSep 25, 20251 year ago
SMA: BullishSep 22, 20251 year ago
SMA: BullishSep 22, 20251 year ago
MACD: Buy SignalSep 22, 20251 year ago
RSI: OverboughtSep 22, 20251 year ago
MACD: Sell SignalSep 4, 20251 year ago
SMA: BearishAug 29, 20251 year ago
SMA: BearishAug 29, 20251 year ago
SMA: BullishAug 27, 20251 year ago
SMA: BullishAug 27, 20251 year ago
RSI: OverboughtAug 27, 20251 year ago
MACD: Buy SignalJul 15, 20251 year ago
SMA: BearishJun 17, 20251 year ago
MACD: Sell SignalJun 17, 20251 year ago
SMA: BullishJun 13, 20251 year ago
SMA: BearishJun 11, 20251 year ago
MACD: Buy SignalJun 5, 20251 year ago
RSI: OverboughtJun 5, 20251 year ago
MACD: Sell SignalMay 28, 20251 year ago
MACD: Buy SignalMay 14, 20251 year ago
SMA: BullishMay 6, 20251 year ago
MACD: Sell SignalMay 1, 20251 year ago
SMA: BearishApr 28, 20251 year ago
RSI: OverboughtApr 25, 20251 year ago
SMA: BullishApr 22, 20251 year ago
MACD: Buy SignalMar 6, 20251 year ago
MACD: Sell SignalFeb 18, 20251 year ago
SMA: BearishFeb 13, 20251 year ago
MACD: Buy SignalFeb 5, 20251 year ago
SMA: BullishFeb 4, 20251 year ago
MACD: Sell SignalJan 14, 20251 year ago
MACD: Buy SignalJan 3, 20251 year ago
RSI: OverboughtJan 3, 20251 year ago

Key statistics

Market cap
346.28K
Enterprise value
-2.97M
Trailing P/E
0.00
Forward P/E
-3.39
PEG ratio
0.00
Price / sales
0.00
Price / book
0.08
EPS (TTM)
-10.66
Beta
1.95
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-5.37M
Total cash
4.12M
Total debt
451.00K
Return on equity
-113.96%
Shares outstanding
1.14M
Short % of float
2.94%
50-day average
1.49
200-day average
2.82

Analyst view

Consensus: hold

Hold
Price target (mean) 0.00

Next earnings

Dec 24, 2024

Expected Dec 24, 2024. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
AMPE Revenue — quarterly 0
2020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 2023
AMPE Net income — quarterly -2.05M
2020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 2023
AMPE EPS — quarterly -2.48
2020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 2023

Earnings

AMPE recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Dec 24, 2024Sep 1, 20240.00———
Oct 1, 2024Jun 1, 20240.00———
Jul 1, 2024Mar 1, 20240.00———
Mar 27, 2024Dec 1, 20230.00-2.48——
Nov 14, 2023Sep 1, 20230.00-1.53——
Aug 8, 2023Jun 1, 20230.00-1.80——

About Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on AMPE — it syncs with the Stock Master app.

Insider holders

AMPE insider holders
InsiderRelationLatest transactionDateShares held
BAR-OR DAVIDDirectorStock Award(Grant)Jan 3, 202192,800
BUCHI J KEVINDirectorPurchaseJun 8, 2023146,858
CHEREVKA HOLLIChief Operating OfficerStock Award(Grant)Oct 10, 2021500,000
COELHO PHILIP HDirectorSaleMay 20, 2021203,500
GILES RICHARD BDirectorStock Award(Grant)Jan 3, 2021367,121
MACALUSO MICHAELChief Executive OfficerStock Award(Grant)Oct 10, 20212,736,750

Institution ownership

AMPE institution ownership
Holder% heldSharesValueReported
HRT Financial LP0.69%5,20224.24KJun 29, 2023
Private Capital Management LLC0.32%2,39711.17KJun 29, 2023
Two Sigma Securities, LLC0.20%1,5077.02KJun 29, 2023
Renaissance Technologies, LLC0.19%1,4256.64KJun 29, 2023
Virtu Financial LLC0.17%1,2655.89KJun 29, 2023
Brighton Jones LLC0.16%1,2305.73KJun 29, 2023
Advertisement